In cancerous cells, EGFR pathway activation results in cell proliferation, inhibition of apoptosis, activation of invasion, metastasis and tumour neovascularisation (Ciardiello and Tortora, 2001, 2008; Cohen et al, 2005). Here, EGFR is linked to neoplasm.